ALTEROLA BIOTECH INC. Overview
Industry: Drug Manufacturers Specialty & Generic
Sector: Healthcare
Alterola Biotech, Inc., a pharmaceutical company, engages in the development of cannabinoid and cannabinoid-like molecules. It focuses on the development of regulated human and animal health pharmaceuticals and regulated food products; production of active pharmaceutical ingredients and food-grade ingredients; and formulation and drug delivery for improved bioavailability, solubility, and stability. The company is based in Birkenhead, the United Kingdom. Alterola Biotech, Inc., a pharmaceutical company, engages in the development of cannabinoid and cannabinoid-like molecules. It focuses on the development of regulated human and animal health pharmaceuticals and regulated food products; production of active pharmaceutical ingredients and food-grade i Read MoreALTEROLA BIOTECH INC. is evaluated based on the investment philosophy and approach to stock market investing developed by renowned investor Warren Buffett. Companies with high ratings typically exhibit growing earnings, a substantial profit margin, conservative leverage, a consistently high return on equity, and a sustained practice of repurchasing their shares over the years.
ALTEROLA BIOTECH INC.
Score
Reported Results
No latest earnings report cached yet
Run the EDGAR earnings refresh to load the latest company-filed earnings release, 10-Q, 10-K, or transcript exhibit for this ticker.
Recent News
Earnings Per Share
Score 1.00/5
ALTEROLA BIOTECH INC. earns a low score, as its Earnings Per Share (EPS) has not shown continuous growth over the last six years. Notable counterparts in the sector with high scores includes
Zoetis Inc
IQVIA Holdings Inc
Agilent Technologies Inc
In
Drug Manufacturers Specialty & Generic industry
, Zoetis Inc
, Amphastar P
, Prestige Consumer Healthcare
are companies with high ratings.
Return on Equity
Score 1.93/5
ALTEROLA BIOTECH INC. exhibits a lower score in the Return on Equity (ROE) section, falling below the sector median value and indicating a comparatively weaker performance in this metric. The top companies in the same sector include
Zoetis Inc
IQVIA Holdings Inc
Agilent Technologies Inc
0%
10%
20%
30%
40%
ROE
Company 0%
Sector Median 0%
0%
10%
20%
30%
40%
ROE
Company 0%
Sector Median 0%
0%
10%
20%
30%
40%
ROE
Company 0%
Sector Median 0%
0%
10%
20%
30%
40%
ROE
Company 0%
Sector Median 0%
Metric chart temporarily unavailable.
Net Margin
Score 2.21/5
ALTEROLA BIOTECH INC.
olds a low score as its net margin consistently trails below the sector median value and doesn't exhibit continuous growth over the last six years; notable companies in the sector with commendable scores include
Zoetis Inc
IQVIA Holdings Inc
Agilent Technologies Inc
0%
10%
20%
30%
40%
Net Margin
Company 0%
Sector Median 0%
0%
10%
20%
30%
40%
Net Margin
Company 0%
Sector Median 0%
0%
10%
20%
30%
40%
Net Margin
Company 0%
Sector Median 0%
0%
10%
20%
30%
40%
Net Margin
Company 0%
Sector Median 0%
Metric chart temporarily unavailable.
Leverage
Score 3.00/5
ALTEROLA BIOTECH INC.
attains a commendable score in the category due to its lower leverage ratio over the past six years in comparison to the sector median value. Additionally, other notable companies in the same sector, such as
Zoetis Inc
IQVIA Holdings Inc
Agilent Technologies Inc
, also exhibit high scores.
0
1
2
3
4
Leverage
Company 0
Sector Median 0
0
1
2
3
4
Leverage
Company 0
Sector Median 0
0
1
2
3
4
Leverage
Company 0
Sector Median 0
0
1
2
3
4
Leverage
Company 0
Sector Median 0
Metric chart temporarily unavailable.
Financial Statements
Company-reported SEC EDGAR facts organized into the three core statements.
SEC financial statements are temporarily unavailable.
Source: SEC EDGAR companyfacts. Values are standardized company filings for research support, not personalized financial advice.
Financial Ratio
Yearly
Quarterly
Financial
Profitability
Growth
Cash Flow
Financial Health
Efficiency Ratios